Literature DB >> 11829095

International approaches to the prescription of long-term oxygen therapy.

P J Wijkstra1, G H Guyatt, N Ambrosino, B R Celli, R Güell, J F Muir, C Préfaut, E S Mendes, I Ferreira, P Austin, B Weaver, R S Goldstein.   

Abstract

While there is broad agreement about who should receive long-term oxygen therapy (LTOT), there is little information available on how clinicians should decide on the oxygen prescription itself, at rest, during sleep and during exercise. The authors describe the results of an international survey that was undertaken to compare how respirologists prescribed oxygen. A questionnaire was sent to 100 respirologists in each of seven countries. The questionnaire identified whether resting flow rates were derived in a standard manner or by individualized patient testing. Test targets were ascertained for rest, exercise and sleep, as was the percentage of time that each test target had to reach for the test to be accepted. The majority of respondents individualized the oxygen prescription at rest (81%). Resting arterial oxygen saturation (Sa,O2) was most commonly targeted at 90-91%. The approach to night prescription varied (p<0.001). Respirologists in Canada and the USA increased the resting Sa,O2 by 1-2 L x min(-1) during sleep, while those in Spain used the resting (awake) flow for the night prescription (62%). Respirologists in the Netherlands, France, and Italy individualized the night prescription more frequently. Although oxygen during exercise was individualized in most countries (74%), significant differences remained among countries (p<0.001). The majority of respirologists (62%) aimed to achieve an Sa,O2 of 90-91% during exercise, while 70% of all respirologists tried to achieve the desired Sa,O2 for 90% of the test. There were substantial differences among countries as to how the oxygen prescription was written. This survey highlights the need for multicentre studies that improve the effectiveness of long-term oxygen therapy utilization.

Entities:  

Mesh:

Year:  2001        PMID: 11829095     DOI: 10.1183/09031936.01.00202301

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Got a match? Home oxygen therapy in current smokers.

Authors:  Y Lacasse; J LaForge; F Maltais
Journal:  Thorax       Date:  2006-05       Impact factor: 9.139

2.  Overnight prescription of oxygen in long term oxygen therapy: time to reconsider the guidelines?

Authors:  M Nisbet; T Eaton; C Lewis; W Fergusson; J Kolbe
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

3.  Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals.

Authors:  Alessia Verduri; Licia Ballerin; Marzia Simoni; Marcello Cellini; Emidia Vagnoni; Pietro Roversi; Alberto Papi; Enrico Clini; Leonardo M Fabbri; Alfredo Potena
Journal:  Intern Emerg Med       Date:  2013-01-18       Impact factor: 3.397

4.  Nocturnal oxygen therapy in patients with chronic obstructive pulmonary disease: a survey of Canadian respirologists.

Authors:  Yves Lacasse; Frédéric Sériès; Sylvie Martin; François Maltais
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

5.  Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Authors:  Yves Lacasse; Sarah Bernard; Frédéric Sériès; Van Hung Nguyen; Jean Bourbeau; Shawn Aaron; François Maltais
Journal:  BMC Pulm Med       Date:  2017-01-09       Impact factor: 3.317

Review 6.  Continuous remote monitoring of COPD patients-justification and explanation of the requirements and a survey of the available technologies.

Authors:  Ivan Tomasic; Nikica Tomasic; Roman Trobec; Miroslav Krpan; Tomislav Kelava
Journal:  Med Biol Eng Comput       Date:  2018-03-05       Impact factor: 2.602

Review 7.  Long-term oxygen therapy: are we prescribing appropriately?

Authors:  Rosa Güell Rous
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 8.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

9.  A nationwide structure for valid long-term oxygen therapy: 29-year prospective data in Sweden.

Authors:  Magnus Ekström; Zainab Ahmadi; Hillevi Larsson; Tove Nilsson; Josefin Wahlberg; Kerstin E Ström; Bengt Midgren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-30

Review 10.  [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis].

Authors:  Anna Serrano-Mollar
Journal:  Arch Bronconeumol       Date:  2012-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.